Archives
-
5-Azacytidine Reprograms Dormant Cancer Cells
2026-09-01
Singh et al. show that sequential 5-Azacytidine and retinoic-acid-receptor agonist treatment can reprogram disseminated cancer cells into a stable dormant state rather than simply eliminating them. The study links metastatic suppression to restoration of TGF-β–SMAD4 signaling and identifies SMAD4 loss as a mechanism of resistance, offering a framework for studying therapeutic control of residual disease.
-
Cholesterol for mRNA-LNP Research
2026-08-31
Cholesterol is the principal sterol for membrane engineering, liposome development, and mRNA–lipid nanoparticle workflows. This guide translates localized p21 mRNA delivery findings into practical formulation, membrane fluidity assay, storage, and troubleshooting strategies using a defined cholesterol research compound.
-
JNJ-10198409 for PDGF Receptor Signaling Studies
2026-08-31
JNJ-10198409 is a nanomolar platelet-derived growth factor receptor inhibitor for dissecting PDGF-BB-driven proliferation, migration, angiogenesis, and fibrosis-related phenotypes. This practical guide combines concentration planning, time-resolved pathway measurements, assay controls, and troubleshooting with a cautious cross-domain interpretation of recent kinase-signaling research.
-
Pravastatin Sodium in Hepatocyte Interaction Studies
2026-08-30
Pravastatin sodium offers more than cholesterol biosynthesis inhibition: it can serve as a mechanistic perturbation in hepatocyte and transporter studies. This article explains how to integrate HMG-CoA reductase inhibition with viability, gene-expression, and functional transport assays for more defensible interpretation.
-
Plant Cell Lysis Buffer: Preserve Signaling Evidence
2026-08-29
Plant Cell Lysis Buffer for WB and IP supports native protein extraction while protecting phosphorylation and protein complexes. This article presents an assay-selection framework inspired by MAPK10–KRT16 signaling research, helping researchers match lysis chemistry to the biological question.
-
Sulfo-Cy5 NHS Ester for Reliable Cell Assays
2026-08-28
Learn how Sulfo-Cy5 NHS ester (SKU A8108) supports aqueous protein labeling, far-red cellular imaging, and more interpretable viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects spectral specifications, handling controls, assay design, and vendor-selection criteria to practical laboratory decisions.
-
PDHA1 Succinylation and α-KGA in Cholangiocarcinoma
2026-08-28
A 2025 Nature Communications study identifies a PDHA1 K83 succinylation–α-KGA–OXGR1 axis that connects cholangiocarcinoma metabolism with impaired macrophage antigen presentation. The findings provide a mechanistic framework for studying chemotherapy resistance and suggest that disrupting this metabolic and post-translational pathway may improve gemcitabine–cisplatin responses, although clinical translation remains unproven.
-
Cy3 Goat Anti-Human IgG: Assay Design Guide
2026-08-27
The Cy3 Goat Anti-Human IgG (H+L) Antibody supports precise fluorescent detection of human IgG across imaging, tissue, cytometric, and immunoassay workflows. This guide adds a host-species and assay-architecture perspective, using orthopoxvirus antibody research to clarify when fluorescence is informative—and when it is not a substitute for functional testing.
-
Serine/Glycine Restriction, PD-L1 Lactylation, and CRC
2026-08-27
A 2024 Cell Metabolism study shows that a serine/glycine-free diet can suppress colorectal cancer growth and increase cytotoxic T-cell accumulation, while also inducing PD-L1 lactylation that supports immune escape. The work links dietary metabolism to checkpoint regulation and provides early clinical evidence that this nutritional intervention is feasible and safe, although its therapeutic efficacy still requires controlled trials.
-
GS-441524: From Metabolite to Translational Strategy
2026-08-26
GS-441524 sits at the intersection of nucleoside pharmacology, antiviral assay design, and prodrug innovation. This article translates recent LC–MS/MS evidence on GS-441524 prodrug conversion into practical guidance for exposure control, parent–metabolite interpretation, and translational study planning.
-
CCK-8 Ammonium: A Translational Signaling Probe
2026-08-26
Cholecystokinin octapeptide ammonium is best viewed as a sulfation-dependent perturbation tool for resolving how CCK1R and CCK2R signaling connects brain, behavior, survival, immunity, and cardiac endocrine biology. This perspective translates zebrafish evidence into practical study-design guidance while defining the boundaries between mechanistic promise and clinical readiness.
-
EdU Flow Cytometry Assay Kits (Cy5): Workflow
2026-08-25
EdU Flow Cytometry Assay Kits (Cy5) provide a practical method for measuring DNA synthesis during S-phase using CuAAC click chemistry and Cy5 fluorescence. The workflow is intended for research flow cytometry, cell-cycle, genotoxicity, and pharmacodynamic studies, but it should not be treated as a clinical diagnostic or in vivo labeling method without separate validation.
-
Hydroxychloroquine Sulfate: Protocol Guide
2026-08-25
Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research reagent for probing autophagy pathway modulation and TLR7/9-dependent immune signaling. It is suitable for controlled cell and animal studies but should not be selected for workflows requiring DMSO or ethanol solubility or long-term storage of prepared solutions.
-
Dihydroartemisinin: Bench Workflow Guide
2026-08-24
Dihydroartemisinin supports reproducible malaria, inflammatory, psoriasis, and cell-signaling studies when solvent handling, light protection, and orthogonal readouts are controlled. This practical guide translates its product specifications and the phebestin antiplasmodial workflow into assay-ready decisions without conflating evidence from different compounds.
-
Bestatin Hydrochloride as a Mechanistic Assay Probe
2026-08-24
Bestatin hydrochloride, also known as Ubenimex, is more than a broad aminopeptidase inhibitor. This article presents a practical assay framework linking substrate processing, neuronal signaling, angiogenesis inhibition, and tumor phenotypes while clarifying what the foundational evidence can—and cannot—establish.